Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

150
Has over 150 years of combined biotech/pharma industry experience

35
Has been directly involved in over 35 Investigational New Drug applications (INDs)

70
Are responsible for 70 therapeutics currently in the clinic

$2.1B
Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

Access the National Drug Discovery Centre’s ultra-high throughput screening capabilities at a 90% subsidy.

Round 3 applications for #MRFF subsidised screens close 21 January 2021.

More info at https://nddc.wehi.edu.au/

#NDDC #WEHIDrugDiscovery

There are a range of strategies to ensure scientific rigour when using antibodies in early-stage research. By operating in line with industry standards, researchers can ‘fast track’ their early-stage research towards biopharma investment. More https://nuvi.me/pg3zc0

Dr Eric Hayes is on a mission to find better drugs, with a passion for improving the lives, empathy for researchers working under difficult circumstances and understanding what investors and potential partners need to get discoveries to patients. Read more https://nuvi.me/bo9svo